BCM
CORZ icon

Brookstone Capital Management’s Core Scientific CORZ Stock Holding History

Brookstone Capital Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$582K Buy
+22,725
New +$535K 0.01% 880

Other funds holding CORZ

CCAM
Capelight Capital Asset Management New York $208M AUM
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SCP
Silverleafe Capital Partners Germantown, Tennessee $367M AUM 37.49% 1-Year Est. Return
RA
REX Advisers Fairfield, Connecticut $44.3M AUM
MNBTD
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 38.93% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
TAM
Titleist Asset Management San Antonio, Texas $1.49B AUM 22.27% 1-Year Est. Return

Brookstone Capital Management's CORZ Position: Q2 2026 in Review

Brookstone Capital Management opened a new position in Core Scientific (CORZ) in Q2 2026: 22,725 shares worth $582K. The stake represents 0.01% of the portfolio and ranks #880 among its holdings.

45 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Brookstone Capital Management held 22,725 shares of Core Scientific worth $582K as of Q2 2026.
  • Core Scientific was a new Brookstone Capital Management position in Q2 2026.
  • Core Scientific made up 0.01% of Brookstone Capital Management's portfolio in Q2 2026, its #880 holding.
  • 45 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.